Ycovid-19 aims to be a rapid diagnostic test for SARS-CoV-2 infection, which will allow a reliable diagnosis to be made in 10 minutes, and on easy-to-use devices. This test will be developed using innovative technology developed at the Parc Taulí University Hospital, which increases the immunogenicity of SARS-CoV-2 differential antigens. The increased immunogenicity of these antigens will allow to detect, with a high sensitivity and specificity, the antibodies in the serum of patients infected with SARS-CoV-2. This test will serve to confirm dubious results as well as reduce false negatives from the PCR test, which will ultimately help reduce transmission of the infection.
Study Type
OBSERVATIONAL
Enrollment
3,500
Ycovid-19 aims to be a rapid diagnostic test for SARS-CoV-2 infection, which will allow a reliable diagnosis to be made in 10 minutes, and on easy-to-use devices
Parc Tauli University Hospital
Sabadell, Barcelona, Spain
IgG anti-COVID-19
IgG antibodies against COVID-19 RBD
Time frame: From May to July
IgM anti-COVID-19
IgM antibodies against COVID-19 RBD
Time frame: From May to July
IgA anti-COVID-19
IgA antibodies against COVID-19 RBD
Time frame: From May to July
Time of onset symptoms
Time frame: From May to July
COVID-19 PCR results
Qualitative result to clasify patients into PCR COVID-19 positive patients and PCR COVID-19 negative patients
Time frame: From May to July
Radiological studies
The presence or abcense of the typical image of the pneumonia caused by COVID-19
Time frame: From May to July
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.